By Iwao Ojima, Gregory D. Vite, Karl-Heinz Altmann
content material: melanoma drug discovery and improvement : new paradigms for a brand new millennium / E.A. Sausville ... [et al.] --
Evolutionary biosynthesis of anticancer medications / George R. Pettit --
a few fresh advancements within the synthesis and structure-activity courting of novel taxanes / John F. Kadow ... [et al.] --
New new release taxoids and hybrids of microtubule-stabilizing anticancer brokers / Iwao Ojima ... [et al.] --
Discodermolide and taxol : a synergistic drug mix in human carcinoma cellphone strains / Susan Band Horwitz ... [et al.] --
hugely effective semisynthesis of biologically lively epothilone derivatives / Gregory D. Vite ... [et al.] --
artificial and semisynthetic analogs of epothilones : chemistry and organic job / Karl-Heinz Altmann ... [et al.] --
Synthesis and organic task of epothilones / Ulrich Klar ... [et al.] --
Epothilones and sarcodictyins : from combinatorial libraries to designed analogs / Nicolas Winssinger and K.C. Nicolaou --
Synthesis and structure-activity dating experiences of cryptophycins : a singular category of powerful antimitotic antitumor depsipeptides / Chuan Shih ... [et al.] --
Farnesyltransferase inhibitors as capability anticancer brokers / J.B. Gibbs ... [et al.] --
Farnesyltransferase inhibitors : from squalene synthase inhibitors to the medical agent BMS-214662 / John T. Hunt --
Inhibiting farnesyl protein transferase with Sch-66336 : most likely a selective noncytotoxic treatment for human melanoma / A.G. Taveras ... [et al.] --
Pyrrolo[2,3-d]pyrimidine and pyrazolo[3,4-d]pyrimidine derivatives as selective inhibitors of the EGF receptor tryosine kinase / G. Caravatti ... [et al.] --
STI571 : a brand new remedy modality for CML? / Jürg Zimmermann, Pascal Furet, and Elisabeth Buchdunger --
the invention and improvement of second-generation matrix metalloproteinase inhibitors for the remedy of melanoma / Andy Baxter and John Montana --
customers for antiangiogenic treatments dependent upon VEGF inhibition / Pascal Furet and Paul W. Manley --
Carbohydrate-based tumor antigens as antitumor vaccine brokers / Jennifer R. Allen and Samuel J. Danishefsky --
medications to augment the healing efficiency of anticancer antibodies : antibody-drug conjugates as tumor-activated prodrugs / Walter A. Blättler and Ravi V.J. Chari.
Read or Download Anticancer Agents. Frontiers in Cancer Chemotherapy PDF
Similar oncology books
On March 2, 1994, the service provider for health and wellbeing Care coverage and study (a department of the general public well-being carrier) made headlines via freeing new melanoma discomfort administration instructions. That record published that soreness is usually undertreated, and that aid is not just attainable for many sufferers, yet really aids in restoration.
During this first authoritative evaluate on smooth melanoma chemotherapy 121 foreign experts have contributed their adventure and up to date info for what's more likely to develop into the most suitable within the box. The authors summarize wisdom received during the last decade, from easy options to profitable purposes within the sanatorium, overlaying energetic and passive concentrating on ideas in addition to tissue-specific techniques.
''Written for discomfort administration Practitioners, Oncologists, Oncology Nurses, Nurse Practitioners, Social staff, Pharmacologists, and first Care Practitioners, in addition to scholars in those fields, this reference presents perception into chemotherapy-induced neuropathic ache melanoma survivors endure. It reports the fundamental and medical examine into the conventional body structure of soreness transmission pathways, neuropathic discomfort pathology, the chemotherapeutic drug mechanisms of motion and antagonistic results, chemotherapy-induced neuropathy, and drug discovery efforts for therapy.
Every one quantity within the Early Detection and remedy of melanoma sequence is filled with sensible, authoritative info designed to hide the total diversity of diagnostic techniques, together with pathologic, radiologic, bronchoscopic, and surgical features. You’ll have the capacity to make sure the most secure, shortest, least invasive option to succeed in a correct analysis; degree the disorder; and select the easiest preliminary remedy for early phases.
- Antibody-Drug Conjugates
- Signal Transduction in Cancer (Cancer Treatment and Research), 1st Edition
- Taxane Anticancer Agents: Basic Science and Current Status (ACS Symposium Series)
- Supportive Oncology: (Expert Consult - Online and Print), 1e (Expert Consult Title: Online + Print)
- Oral Complications of Cancer and its Management
Additional info for Anticancer Agents. Frontiers in Cancer Chemotherapy
Duffy, K . ; Stevens, K . ; Dalko, P. ; Roth, R. ; Hayward, M. ; Kishi, Y . Angew. , Int. Ed. Engl. 1998, 37, 187-192. Hayward, M. ; Roth, R. ; Duffy, K . J . ; Dalko, P. ; Stevens, K . ; Kishi, Y. Angew. Chem. Int. Ed. Engl. 1998, 37, 192-196. Evans, D . ; Trotter, B . W . ; Coleman, P. J . ; Côté, B . ; Dias, L. ; Rajapakse, Η. ; Tyler, A . N. Tetrahedron 1999, 55, 8671-8726. Claffey, M. ; Hayes, C . J . ; Heathcock, C . H. J. Org. Chem. 1999, 64, 8267-8274. ; Guyot, M. Tetrahedron Lett. 2000, 41, 3349-3353.
70. 71. 72. 73. 74. 75. 76. 77. 78. ; Loadman, P. ; Swaine, D . J . ; Pettit, G . R . ; Bibby, M. C. Anticancer Res. 2000, 20, 229-234. ; Zhou, B - N . ; Glass, T. ; Shap, J . ; Mattern, M. ; Johnson, R. ; Kingston, D . G . I. J. Nat. Prod. 2000, 63, 457-460. Pettit, G . ; Cragg, G . ; Gust, D . ; Brown, P . ; Schmidt, J . M. Can. J. Chem. 1982, 60, 939-941. Pettit, G . ; Cragg, G . ; Brown, P. Can. J. Chem. 1982, 60, 544-546. Pettit, G . ; Cragg, G . ; Niven, M. ; Nassimbeni, L. R. Can. J. Chem.
However, these positions play an important role in the in vivo efficacy of the taxanes. They may modulate the solubility, pharmacokinetics, metabolism, and distribution of the compounds in the body. Previously we and others have described 7-deoxy(26-28), 7-halo(29, 30), or 7,19 cyclopropane derivatives(29-32), many incorporating modified sidechains. During the course of our program and others, 7 ethers, acetal ethers, and methyl thioethyl ethers(33-35), were also prepared. Modifications at the C-7 position of paclitaxel have been shown to reduce the effect of p-glycoprotein mediated multiple drug resistance in cancer cells(18, 36, 37) and now we also describe some modifications which can produce this effect.